• Home
  • Our commitment to transparency

Our commitment to transparency

LEO Pharma is transparent about information and results from our clinical trials. Our aim is to enable patients and health-care professionals to take informed decisions about treatment, facilitated by the availability of both historical clinical trial information and information from the latest projects in clinical development.

Clinical trial disclosure

Currently, our commitments to clinical trial transparency apply to all interventional clinical trials conducted by LEO Pharma (including drug-device combination trials). Оur transparency framework meets, and in some cases exceeds, existing requirements from regulatory authorities and major industry associations regarding disclosure of clinical trial information.
All our clinical transparency activities carefully take the privacy of our trial participants into account, and we maintain their anonymity by protecting personal sensitive information using state-of-the art techniques.